Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA warning on Multaq emphasizes risks for patients with permanent heart irregularity
FDA warning on Multaq emphasizes risks for patients with permanent heart irregularity
FDA warning on Multaq emphasizes risks for patients with permanent heart irregularity
Submitted by
admin
on December 19, 2011 - 4:01pm
Source:
Yahoo/AP
News Tags:
FDA
Multaq
Sanofi
Headline:
FDA warning on Multaq emphasizes risks for patients with permanent heart irregularity
Do Not Allow Advertisers to Use My Personal information
